Drawing for REPLICART

USPTO serial 79074230

REPLICART

Reviewed by CopyMark Law Group

Reg. 3879243Status 404
Filing date
Status date
Registration date
Nov 23, 2010
Examiner
FAIRBANKS, RONALD L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REPLICART?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1100 New York Avenue, N.W.Washington, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, management, diagnosis and treatment of osteoarthritis, veterinary preparations for the prevention, management, diagnosis and treatment of osteoarthritis, biotechnology preparations for the prevention, management, diagnosis and treatment of osteoarthritis, and medical preparations for the prevention, management, diagnosis and treatment of osteoarthritis; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluids, namely, cultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes but not including embryonic stem cells; human cells, namely, stem cells but not including embryonic stem cells, animal cells, namely, stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatment, reconstruction and repair of tissue but not including preparations for embryonic stem cells; vitamins, minerals, nutritional supplements and foodstuffs in this class are excludedSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 6, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 6, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 6, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 12, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 12, 2018INPCINVALIDATION PROCESSED—
Feb 28, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 7, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 30, 2017C71TCANCELLED SECTION 71—
May 25, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 17, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 30, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 18, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 7, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 7, 2011FIMPFINAL DISPOSITION PROCESSED—
Feb 23, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 23, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 7, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 18, 2010NPUBNOTICE OF PUBLICATION—
Jul 31, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 31, 2010ALIEASSIGNED TO LIE—
Jul 17, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 7, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 8, 2010CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 7, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 4, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 25, 2009RFNPREFUSAL PROCESSED BY IB—
Dec 4, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 4, 2009RFRRREFUSAL PROCESSED BY MPU—
Dec 4, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 3, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2009DOCKASSIGNED TO EXAMINER—
Nov 21, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 17, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance